BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 13563000)

  • 21. Analeptic action of lysergic acid diethylamide (LSD-25) against pentobarbital.
    APTER JT
    AMA Arch Neurol Psychiatry; 1958 Jun; 79(6):711-5. PubMed ID: 13532082
    [No Abstract]   [Full Text] [Related]  

  • 22. Drugs that antagonize limb flick behavior induced by D-lysergic acid diethylamide (LSD) in cats.
    Haigler HJ; Spring DD
    Psychopharmacology (Berl); 1979 Jun; 64(1):31-4. PubMed ID: 113828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of LSD-25, chlorpromazine and metedrine upon visual evoked response in cats.
    Buño W; Villar JI; Tejerina W; García-Ausit E
    Acta Neurol Latinoam; 1970; 16(1):64-73. PubMed ID: 5538058
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of LSD, BOL, and chlorpromazine on "neurohormone" metabolism.
    SIVA SANKAR DV; PHIPPS E; GOLD E; SANKAR DB
    Ann N Y Acad Sci; 1962 Jan; 96():93-7. PubMed ID: 13913509
    [No Abstract]   [Full Text] [Related]  

  • 25. [ON THE FREE AND BOUND CENTRAL NERVOUS SYSTEM INHIBITORY SUBSTANCE IN THE MAMMAL].
    UMRATH K; BOHN H
    Pflugers Arch Gesamte Physiol Menschen Tiere; 1963 Sep; 277():523-36. PubMed ID: 14090030
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of psychotherapeutic compounds on central afferent and limbic pathways.
    KILLAM EK; KILLAM KF; SHAW T
    Ann N Y Acad Sci; 1957 Mar; 66(3):784-805. PubMed ID: 13425260
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of central excitant and depressant drugs on locomotor activity in the monkey.
    DAVIS GD
    Am J Physiol; 1957 Mar; 188(3):619-23. PubMed ID: 13411268
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of drugs on discrimination and sensory generalisation of auditory stimuli in cats.
    KEY BJ
    Psychopharmacologia; 1961; 2():352-63. PubMed ID: 14455464
    [No Abstract]   [Full Text] [Related]  

  • 29. Tolerance develops to LSD while the drug is exerting its maximal behavioral effects: implications for the neural bases of tolerance.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1983 Dec; 96(3-4):317-20. PubMed ID: 6676109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of the brain.
    Valdman AV
    Nurs Mirror Midwives J; 1967 Apr; 124(4):1-92. PubMed ID: 5336687
    [No Abstract]   [Full Text] [Related]  

  • 31. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of bufotenine-like syndrome induced by diethyltryptamine in reserpinized rats.
    Khazan N; Hirsch A; Sulman FG
    Electroencephalogr Clin Neurophysiol; 1967 Jun; 22(6):589. PubMed ID: 4165027
    [No Abstract]   [Full Text] [Related]  

  • 33. Reserpine action on the central nervous system of the cat.
    HAMEL EG; KAELBER WW
    Am J Physiol; 1961 Feb; 200():195-200. PubMed ID: 13710985
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of drugs on uptake and exit of cerebral amino acids.
    Lajtha A; Toth J
    Biochem Pharmacol; 1965 May; 14(5):729-38. PubMed ID: 5840727
    [No Abstract]   [Full Text] [Related]  

  • 35. Chlorpromazine-lysergic acid diethylamide antagonism.
    Matin MA; Vijayvargiya R
    J Pharm Pharmacol; 1967 Mar; 19(3):192-3. PubMed ID: 4382342
    [No Abstract]   [Full Text] [Related]  

  • 36. Vesicular and juxtavesicular serotonin: effects of lysergic acid diethylamide and reserpine.
    Halaris AE; Freedman DX
    J Pharmacol Exp Ther; 1977 Dec; 203(3):575-86. PubMed ID: 925959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication; effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine.
    CLARK LD; BLISS EL
    AMA Arch Neurol Psychiatry; 1957 Dec; 78(6):653-5. PubMed ID: 13478222
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of phenobarbitone, leptazol, dexamphetamine, iproniazid, imipramine, LSD, chlorpromazine, reserpine and hydroxyzine on the in vivo levels of adenine nucleotides and phosphocreatine in the rat brain.
    Wilson WS
    Br J Pharmacol; 1969 Jul; 36(3):448-57. PubMed ID: 4239802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accentuation of the psychological effects of LSD-25 in normal subjects treated with reserpine.
    Resnick O; Krus DM; Raskin M
    Life Sci; 1965 Jul; 4(14):1433-7. PubMed ID: 5850269
    [No Abstract]   [Full Text] [Related]  

  • 40. Lysergic acid diethylamide (LSD-25) antagonists: chlorpromazine.
    ABRAMSON HA; ROLO A; STACHE J
    J Neuropsychiatr; 1960; 1():307-10. PubMed ID: 13791577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.